The development of immunotherapies to treat cancer has transformed the way clinicians think about managing their patients with many forms of malignancies. The speed, at which basic science and clinical trial information continues to emerge in this area, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the-art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology.
"But, how do I use this information to manage my patients with cancer?"
This is the key question, and the one whose answer ultimately means the most to your patients. The International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application will do just that, by answering that question. This exciting, fast-paced, and interactive Congress will provide a focused, multi-module curriculum-based program, exclusively on immunotherapies and their application to the management of cancer. This intensive, 1-day interactive program will provide a comprehensive review of key data sets, most relevant to the application of these novel strategies for the clinician who manages some of the most difficult-to-treat forms of cancer. The program will focus on the practical application of recent clinical trial results that have shaped current and evolving clinical management, evolving biomarker information, the latest basic science findings, and the most highly anticipated clinical trials in the field.
This educational program is directed toward oncologists, nurses, and pharmacists. Participants will be primarily those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the immunotherapies, and their evolving roles in the treatment of cancer.
At the conclusion of this activity, participants should be better prepared to:
Antoni Ribas, MD, PhD
Professor of Medicine
Professor of Surgery
Professor of Molecular & Medical Pharmacology
David Geffen School of Medicine
Director, Tumor Immunology Program, Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Los Angeles, California, USA
Naiyer A. Rizvi, MD
Director, Thoracic Oncology
Price Chair, Clinical Translational Research
Columbia University Medical Center
New York, NY
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY